lncRNA PITPNA-AS1靶向miR-367-3p调控多发性骨髓瘤细胞增殖、迁移和侵袭的分子机制
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Molecular mechanism of lncRNA PITPNA-AS1 targeting miR-367-3p to regulate the proliferation,migration and invasion of multiple myeloma cells
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨长链非编码RNA (lncRNA)PITPNA反义RNA 1(PITPNA-AS1)靶向miR-367-3p调控多发性骨髓瘤细胞增殖、迁移和侵袭的分子机制。方法定量实时聚合酶链反应(qRT-PCR)测定多发性骨髓瘤细胞系RPMI-8226、MM1. S、OPM-2中lncRNA PITPNA-AS1和miR-367-3p表达。在RPMI-8226细胞中转染si-NC (si-NC组)、si-lncRNA PITPNA-AS1(si-lncRNA PITPNA-AS1组)、miR-NC (miR-NC组)、miR-367-3p mimics (miR-367-3p组),或同时转染anti-miR-NC与si-lncRNA PITPNA-AS1(anti-miR-NC+si-lncRNA PITPNA-AS1组)、anti-miR-367-3p与si-lncRNA PITPNA-AS1(anti-miR-367-3p+si-lncRNA PITPNA-AS1组),并将未转染的细胞设为对照组(NC组)。采用Western Blot、细胞计数试剂盒8(CCK-8)、细胞克隆形成实验和Transwell实验分别测定RPMI-8226细胞的基质金属蛋白酶(MMP)2、MMP9蛋白表达、细胞活力、克隆形成和迁移、侵袭。双荧光素酶活性检测实验分析lncRNA PITPNA-AS1和miR-367-3p的靶向关系。结果与成骨细胞MC3T3-E1比较,多发性骨髓瘤细胞系RPMI-8226、MM1. S、OPM-2中lncRNA PITPNA-AS1表达量均增加,miR-367-3p的表达量均减少(P<0.05)。干扰lncRNA PITPNA-AS1或miR-367-3p高表达显著降低RPMI-8226细胞的MMP2蛋白、MMP9蛋白的表达量,并降低细胞活力、克隆形式数、迁移和侵袭数量(均P<0.05)。lncRNA PITPNA-AS1靶向调控miR-367-3p的表达。anti-miR-367-3p可以逆转干扰lncRNA PITPNA-AS1对多发性骨髓瘤细胞RPMI-8226增殖、迁移和侵袭的影响。 结论干扰lncRNA PITPNA-AS1通过靶向调控miR-367-3p,从而抑制多发性骨髓瘤细胞的增殖、迁移和侵袭。

    Abstract:

    【Abstract】 Objective To study the molecular mechanism of whether long-chain non-coding RNA (lncRNA) PITPNA antisense RNA 1 (PITPNA-AS1) targets miR-367-3p to regulate the proliferation,migration and invasion of multiple myeloma cells. MethodsQuantitative real-time polymerase chain reaction (qRT-PCR) was used to determine the expression of lncRNA PITPNA-AS1 and miR-367-3p in multiple myeloma cell lines RPMI-8226,MM1. S,and OPM-2. Transfected si-NC (si-NC group),si-lncRNA PITPNA-AS1 (si-lncRNA PITPNA-AS1 group),miR-NC (miR-NC group),miR-367-3p mimics (miR-367-3p group) into RPMI-8226 cells,or transfected anti-miR-NC and si-lncRNA PITPNA-AS1 (anti-miR-NC+si-lncRNA PITPNA-AS1 group),anti-miR-367-3p and si-lncRNA PITPNA-AS1 (anti-miR-367-3p+si-lncRNA PITPNA-AS1 group) at the same time,and set untransfected cells as control (NC group). Western Blot,cell counting kit 8 (CCK-8),cell clone formation experiment and Transwell experiment were employed to determine matrix metalloproteinase (MMP)2,MMP9 protein expression,cell viability,clone formation and migration,and invasion of RPMI-8226 cells. The dual luciferase activity detection experiment analyzed the targeting relationship between lncRNA PITPNA-AS1 and miR-367-3p. Results Compared with osteoblast MC3T3-E1,the expression of lncRNA PITPNA-AS1 in multiple myeloma cell lines RPMI-8226,MM1. S,and OPM-2 all increased,and the expression of miR-367-3p all decreased (P<0.05). Interfering with lncRNA PITPNA-AS1 or high expression of miR-367-3p significantly reduced the expression of MMP2 protein and MMP9 protein in RPMI-8226 cells,and reduced cell viability,number of clones,migration and invasion (P<0.05). lncRNA PITPNA-AS1 targeted and regulated the expression of miR-367-3p. anti-miR-367-3p can reverse the effect of interfering lncRNA PITPNA-AS1 on the proliferation,migration and invasion of multiple myeloma cells RPMI-8226. ConclusionInterfering lncRNA PITPNAAS1 can inhibit the proliferation,migration and invasion of multiple myeloma cells by targeting miR-367-3p.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-06-20
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司